CASABIANCA, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 7.664
EU - Europa 4.682
AS - Asia 1.492
OC - Oceania 18
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 10
Totale 13.889
Nazione #
US - Stati Uniti d'America 7.640
GB - Regno Unito 2.082
CN - Cina 1.046
UA - Ucraina 730
IT - Italia 604
SE - Svezia 380
TR - Turchia 279
FI - Finlandia 271
DE - Germania 200
IE - Irlanda 171
FR - Francia 130
JP - Giappone 72
RU - Federazione Russa 39
BE - Belgio 26
IN - India 25
CA - Canada 22
SG - Singapore 19
KR - Corea 18
AU - Australia 15
PL - Polonia 14
DK - Danimarca 11
EU - Europa 10
IR - Iran 10
VN - Vietnam 8
CH - Svizzera 6
ES - Italia 6
BR - Brasile 5
CL - Cile 5
TG - Togo 4
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
AM - Armenia 2
AT - Austria 2
BD - Bangladesh 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
EG - Egitto 2
KZ - Kazakistan 2
MD - Moldavia 2
NL - Olanda 2
PA - Panama 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CO - Colombia 1
EC - Ecuador 1
ET - Etiopia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 13.889
Città #
Southend 1.981
Fairfield 1.104
Woodbridge 914
Ann Arbor 847
Houston 819
Jacksonville 587
Ashburn 515
Chandler 470
Seattle 439
Cambridge 422
Wilmington 374
Nanjing 316
Izmir 214
Urbino 205
Dublin 161
Nanchang 134
Helsinki 118
New York 104
Beijing 103
San Mateo 92
Princeton 91
Tianjin 73
Shenyang 71
Boardman 68
Hebei 52
Changsha 51
Istanbul 51
Düsseldorf 48
Bremen 41
Jiaxing 36
San Diego 34
Kunming 33
London 27
Jinan 26
Hangzhou 24
Velikiy Novgorod 24
Brussels 22
San Francisco 21
Seongnam 18
Cagli 16
Toronto 15
Lanzhou 13
Napoli 13
Des Moines 12
Mülheim 12
Kraków 11
Leawood 11
Auburn Hills 10
Ningbo 10
Zhengzhou 10
Augusta 9
Changchun 9
Falls Church 9
Fano 9
Guangzhou 9
Rome 9
Taizhou 9
Milan 8
Orange 8
Redwood City 8
Venice 8
Ardabil 7
Los Angeles 7
Norwalk 7
Osimo 7
Singapore 7
Caserta 6
Dong Ket 6
Frankfurt am Main 6
Munich 6
Shanghai 6
Ancona 5
Tappahannock 5
Cagliari 4
Canberra 4
Chicago 4
Cupra Marittima 4
Dearborn 4
Haikou 4
Hanover 4
Lomé 4
Menlo Park 4
Monmouth Junction 4
Poggio A Caiano 4
Saint-Jeannet 4
Sydney 4
Auckland 3
Clifton 3
Colle Di Val D'elsa 3
Falerone 3
Indiana 3
Jinhua 3
Kilburn 3
Lausanne 3
Montecassiano 3
New Bedfont 3
Nice 3
Pune 3
Rockville 3
Saint Petersburg 3
Totale 11.127
Nome #
Switching to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild†): effects on T-cell compartment and HIV reservoirs 449
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 337
Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources 279
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 218
Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules. 218
A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients 215
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial 214
Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages 208
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 206
A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates 204
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 203
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 201
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 200
Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine 199
Erythrocytes as carriers of antisense PNA addressed against HIV-1 gag-pol transframe domain 199
Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay. 192
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS) 190
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 189
A new one-step RT-PCR method for virus quantitation in murine AIDS. 187
2\',3\'-Dideoxycytidine cytotoxicity in human macrophages. 185
Inhibition of murine AIDS by reduced glutathione. 185
New Approach using the real-time PCR method for estimation of the toxic marine dinoflagellate Ostreopsis cf. ovata in marine environment 185
Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS 185
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 184
2',3'-Dideoxycytidine induced drug resistance in human cells 181
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis 181
Protein degradation and apoptotic death in lymphocytes during fiv infection: activation of the ubiquitin-proteasome proteolytic system , (1999) 381-390 180
Targeting antiviral nucleotide analogues to macrophages 172
Targeting nucleotide dimers containing antiviral nucleosides 170
2',3'-Dideoxycytidine induced drug-resistance in human cells 168
Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy 164
Macrophage protection by nucleoside and nucleotide analogue administration 163
Up-regulation of the ubiquitin-conjugating and proteolytic systems in murine acquired immunodeficiency syndrome 159
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 159
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 158
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial 156
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART 155
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression. 154
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 154
Molecular studies in Duchenne and Becker muscular dystrophies 153
Efficacy and toxicity of long-term administration of 2',3'-dideoxycytidine in the LP-BM5 murine-induced immunodeficiency model 153
Immunophenotype and Function of CD38-Expressing CD4+ and CD8+ T Cells in HIVInfected Patients Undergoing Suppressive Combination Antiretroviral Therapy 153
Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells 153
Human hexokinase type I microheterogeneity is due to different amino-terminal sequences 152
Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection 152
The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system 152
Quantification of the Toxic Dinoflagellate Ostreopsis spp. by qPCR Assay in Marine Aerosol 151
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 150
GSH and analogs in antiviral therapy 147
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 146
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 146
Erythrocyte-based targeted release to macrophages of an azidothymidine homodinucleotide prevents retroviral infection 145
HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis. 144
Macrophage protection by nucleoside and nucleotide analogue administration 143
Protein degradation and apoptotic death in lymphocytes during FIV infection: activation of the ubiquitin-proteasome proteolytic system 142
T-Cell Dynamics and Homeostatic Pathways in HAART-Treated HIV-Infected Patients. 142
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 142
Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5'-triphosphate 140
Monitoring toxic Ostreopsis cf. ovata in recreational waters using a qPCR assay. 138
Efficient inhibition by Raltegravir of HIV-1 Infection in Human Primary Macrophages and in CD4+T Lymphocytes and of the cellular Apoptosis HIV-1 correlated 137
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 137
Targeting antiviral nucleotide analogues to macrophages 134
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 134
Red blood cells as carriers of drugs against retroviruses 133
Human hexokinase type I microheterogeneity is due to different amino-terminal 130
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 130
Hexokinase is not ubiquitaned when mitochondrial-bound 128
Macrophage depletion by Clodronate-loaded erythrocytes 126
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 126
A p12 gag gene homologue is present in the mouse genome. 124
Competitive PCR for quntification of BM5d proviral DNA in mice with AIDS. 123
New drug combinations for the treatment of murine AIDS and macrophage protection. 120
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study 120
Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS 118
Genetic diversity of the genus Ostreopsis Schmidt:phylogeographical considerations and molecularmethodology applications for field detectionin the Mediterranean Sea 116
Studio delle dinamiche di crescita di Ostreopsis cf. ovata con nuove metodologie molecolari di qrt-PCR 115
A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication 115
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 112
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study 108
Role of macrophage protection in the development of murine AIDS. 107
BIOTECNOLOGIE: APPLICAZIONI NEL SETTORE MEDICO E FARMACEUTICO 107
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 101
The inhibitory effect of ddC on HIV replication diminishes in cells that are chronically exposed to the drug 98
Role of macrophage protection in the development of murine AIDS 98
Red blood cells as carriers af antiviral agents 82
Red blood cells as carriers of antiviral agents 79
Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination 69
Comparing Heterologous and Homologous {COVID}-19 Vaccination: A Longitudinal Study of Antibody Decay 44
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment 39
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 37
Prevalence of SARS-CoV-2 infection in the workplace: results of a year of investigation in the Marche Nord companies 35
SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy 35
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation 23
Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis 13
Totale 14.103
Categoria #
all - tutte 41.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.169 548 152 296 790 134 221 240 223 160 196 77 132
2020/20211.860 46 177 143 211 146 118 108 99 354 146 236 76
2021/20221.103 81 95 106 124 29 55 44 57 104 83 65 260
2022/20231.489 182 65 16 184 156 320 7 97 277 60 74 51
2023/2024471 40 34 37 41 34 151 14 29 2 43 3 43
2024/202576 76 0 0 0 0 0 0 0 0 0 0 0
Totale 14.103